Glück Conviction Score™ ⓘ
TARA
Protara Therapeutics, Inc.
ⓘ
Eingeschränkte Aussagekraft — erst 66 % der Signal-Gewichte sind mit Daten unterlegt.
Effektiv: Neutral
Niedrig
Bedeutung der Einstufung ⓘ
Insider
0,0
Keine Insider-Käufe
Institutionell
77,2
29 neu, 47 erhöht, 31,7M $ netto
Aktivist
36,8
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,69% (Stand: 31.05.2026)
Score-Verlauf (90 Tage)
Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.
Kursverlauf (12 Monate)
Technische Indikatoren
Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).
| Indikator | Signal | Gewicht | Wert | Detail | Beitrag |
|---|---|---|---|---|---|
| Kurs vs SMA50 | Bärisch | 10 % | 4.92 | -20.7 % vs SMA50 | |
| Kurs vs SMA200 | Bärisch | 15 % | 5.25 | -25.7 % vs SMA200 | |
| SMA-Cross | Bärisch | 10 % | DEATH | vor 13 Tagen @ 4.80 | |
| EMA20 vs EMA50 | Bärisch | 5 % | 4.37 | EMA50: 4.81 | |
| MACD-Histogramm | Bärisch | 10 % | -0.066 | Bearisch | |
| RSI(14) | Neutral | 10 % | 35.0 | Neutral (30–70) | |
| Stoch %K(14) | Neutral | 5 % | 20.1 | Neutral | |
| ADX(14)+DI | Bärisch | 10 % | 29.4 | +DI: 11.8 / −DI: 31.1 | |
| Z-Score(60) | Bullisch | 5 % | -2.31 | Extrem überverkauft | |
| 52W-Position | Neutral | 5 % | 23.4 % | Hoch 7.56 / Tief 2.78 | |
| Bollinger(20,2σ) | Bullisch | 5 % | 17.4 % | Upper 5.25 / Mid 4.43 / Lower 3.62 | |
| LinReg-Slope(60) | Bärisch | 10 % | -0.0178 | R²=0.46 / annualisiert -90.6 % |
Insider-Transaktionen (12 Monate) ⓘ
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-04-08 | Zummo Jacqueline | Officer, Chief R&D Officer | Open Market Sale | -1.134 | 5,40 | -6.123,60 | -9,8% | |
| 2026-04-01 | Zummo Jacqueline | Officer, Chief R&D Officer | Open Market Sale | -22.598 | 5,26 | -118.865,48 | -190,2% |
Fondsaktivität (Vorquartalsvergleich) ⓘ
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 5.207.011 | 5.141.616 | 65.395 | 27.154.562 | Aufgestockt | +1,3% | |
| BlackRock, Inc. | 3.394.968 | 2.408.868 | 986.100 | 17.687.784 | Aufgestockt | +40,9% | |
| Velan Capital Investment Management LP | 2.834.652 | 2.834.652 | 0 | 14.768.537 | Unverändert | 0,0% | |
| MILLENNIUM MANAGEMENT LLC | 2.831.208 | 753.302 | 2.077.906 | 14.750.594 | Aufgestockt | +275,8% | |
| VANGUARD GROUP INC | 2.391.903 | 0 | 2.391.903 | 12.748.844 | Neu | +100,0% | |
| Blackstone Inc. | 2.265.514 | 0 | 2.265.514 | 11.803.328 | Neu | +100,0% | |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.119.018 | 0 | 2.119.018 | 11.040.084 | Neu | +100,0% | |
| Sio Capital Management, LLC | 1.969.839 | 1.715.394 | 254.445 | 10.262.861 | Aufgestockt | +14,8% | |
| ACORN CAPITAL ADVISORS, LLC | 1.752.115 | 1.752.115 | 0 | 9.128.519 | Unverändert | 0,0% | |
| Integral Health Asset Management, LLC | 1.750.000 | 2.250.000 | -500.000 | 9.117.500 | Reduziert | -22,2% | |
| AIGH Capital Management LLC | 1.622.733 | 0 | 1.622.733 | 8.454.439 | Neu | +100,0% | |
| UBS Group AG | 1.402.413 | 1.215.537 | 186.876 | 7.306.572 | Aufgestockt | +15,4% | |
| 5AM Venture Management, LLC | 1.369.782 | 1.369.782 | 0 | 7.136.564 | Unverändert | 0,0% | |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1.259.427 | 0 | 1.259.427 | 6.712.746 | Neu | +100,0% | |
| CITADEL ADVISORS LLC | 1.232.458 | 931.041 | 301.417 | 6.421.107 | Aufgestockt | +32,4% | |
| GEODE CAPITAL MANAGEMENT, LLC | 1.177.200 | 817.196 | 360.004 | 6.134.752 | Aufgestockt | +44,1% | |
| Point72 Asset Management, L.P. | 1.152.714 | 28.107 | 1.124.607 | 6.005.640 | Aufgestockt | +4001,2% | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.043.478 | 0 | 1.043.478 | 5.561.738 | Neu | +100,0% | |
| Patient Square Capital LP | 1.030.846 | 0 | 1.030.846 | 5.370.708 | Neu | +100,0% | |
| STATE STREET CORP | 1.005.142 | 570.878 | 434.264 | 5.236.790 | Aufgestockt | +76,1% | |
| BAKER BROS. ADVISORS LP | 971.614 | 971.614 | 0 | 5.062.109 | Unverändert | 0,0% | |
| ADAR1 Capital Management, LLC | 940.512 | 1.136.799 | -196.287 | 4.900.068 | Reduziert | -17,3% | |
| BANK OF AMERICA CORP /DE/ | 925.918 | 495.904 | 430.014 | 4.824.033 | Aufgestockt | +86,7% | |
| J. Goldman & Co LP | 856.247 | 0 | 856.247 | 4.461.047 | Neu | +100,0% | |
| Maven Securities LTD | 754.626 | 0 | 754.626 | 4.022.157 | Neu | +100,0% | |
| SPHERA FUNDS MANAGEMENT LTD. | 650.000 | 0 | 650.000 | 3.464.500 | Neu | +100,0% | |
| Catalio Capital Management, LP | 580.024 | 1.446.254 | -866.230 | 3.021.925 | Reduziert | -59,9% | |
| Assenagon Asset Management S.A. | 567.621 | 308.334 | 259.287 | 2.957.305 | Aufgestockt | +84,1% | |
| MORGAN STANLEY | 556.974 | 175.329 | 381.645 | 2.901.834 | Aufgestockt | +217,7% | |
| DIMENSIONAL FUND ADVISORS LP | 531.267 | 227.157 | 304.110 | 2.766.593 | Aufgestockt | +133,9% | |
| Burkehill Global Management, LP | 450.000 | 450.000 | 0 | 2.344.500 | Unverändert | 0,0% | |
| Walleye Capital LLC | 443.401 | 145.876 | 297.525 | 2.310.119 | Aufgestockt | +204,0% | |
| GOLDMAN SACHS GROUP INC | 397.981 | 63.492 | 334.489 | 2.073.481 | Aufgestockt | +526,8% | |
| NORTHERN TRUST CORP | 374.852 | 240.756 | 134.096 | 1.952.979 | Aufgestockt | +55,7% | |
| Alyeska Investment Group, L.P. | 350.000 | 350.000 | 0 | 1.823.500 | Unverändert | 0,0% | |
| OPPENHEIMER & CO INC | 181.565 | 223.767 | -42.202 | 945.954 | Reduziert | -18,9% | |
| Qube Research & Technologies Ltd | 177.004 | 114.331 | 62.673 | 922.191 | Aufgestockt | +54,8% | |
| CIBC WORLD MARKET INC. | 175.495 | 228.895 | -53.400 | 914.329 | Reduziert | -23,3% | |
| JANE STREET GROUP, LLC | 170.235 | 0 | 170.235 | 907.353 | Neu | +100,0% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 172.726 | 148.046 | 24.680 | 899.902 | Aufgestockt | +16,7% | |
| AMERIPRISE FINANCIAL INC | 153.985 | 0 | 153.985 | 820.740 | Neu | +100,0% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 147.888 | 102.499 | 45.389 | 770.496 | Aufgestockt | +44,3% | |
| Monashee Investment Management LLC | 125.000 | 0 | 125.000 | 666.250 | Neu | +100,0% | |
| RENAISSANCE TECHNOLOGIES LLC | 125.700 | 266.807 | -141.107 | 654.897 | Reduziert | -52,9% | |
| SUPERSTRING CAPITAL MANAGEMENT LP | 121.457 | 360.000 | -238.543 | 632.791 | Reduziert | -66,3% | |
| PRUDENTIAL FINANCIAL INC | 119.530 | 0 | 119.530 | 622.751 | Neu | +100,0% | |
| Informed Momentum Co LLC | 103.611 | 0 | 103.611 | 552.247 | Neu | +100,0% | |
| AMERICAN CENTURY COMPANIES INC | 92.969 | 64.158 | 28.811 | 484.368 | Aufgestockt | +44,9% | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 70.330 | 44.830 | 25.500 | 366.419 | Aufgestockt | +56,9% | |
| AQR CAPITAL MANAGEMENT LLC | 66.805 | 14.681 | 52.124 | 348.053 | Aufgestockt | +355,0% |
Top-Fondshalter (Stand: 31.03.2026) ⓘ
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) |
|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 5.207.011 | 5.141.616 | +1,3% | 27.154.562 | 11,64 |
| BlackRock, Inc. | 3.394.968 | 2.408.868 | +40,9% | 17.687.784 | 7,58 |
| Velan Capital Investment Management LP | 2.834.652 | 2.834.652 | 0,0% | 14.768.537 | 6,33 |
| MILLENNIUM MANAGEMENT LLC | 2.831.208 | 753.302 | +275,8% | 14.750.594 | 6,32 |
| Blackstone Inc. | 2.265.514 | 0 | +100,0% | 11.803.328 | 5,06 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.119.018 | 0 | +100,0% | 11.040.084 | 4,73 |
| Sio Capital Management, LLC | 1.969.839 | 1.715.394 | +14,8% | 10.262.861 | 4,40 |
| ACORN CAPITAL ADVISORS, LLC | 1.752.115 | 1.752.115 | 0,0% | 9.128.519 | 3,91 |
| Integral Health Asset Management, LLC | 1.750.000 | 2.250.000 | -22,2% | 9.117.500 | 3,91 |
| AIGH Capital Management LLC | 1.622.733 | 0 | +100,0% | 8.454.439 | 3,62 |
| UBS Group AG | 1.402.413 | 1.215.537 | +15,4% | 7.306.572 | 3,13 |
| 5AM Venture Management, LLC | 1.369.782 | 1.369.782 | 0,0% | 7.136.564 | 3,06 |
| CITADEL ADVISORS LLC | 1.232.458 | 931.041 | +32,4% | 6.421.107 | 2,75 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.177.200 | 817.196 | +44,1% | 6.134.752 | 2,63 |
| Point72 Asset Management, L.P. | 1.152.714 | 28.107 | +4001,2% | 6.005.640 | 2,57 |
| Patient Square Capital LP | 1.030.846 | 0 | +100,0% | 5.370.708 | 2,30 |
| STATE STREET CORP | 1.005.142 | 570.878 | +76,1% | 5.236.790 | 2,24 |
| BAKER BROS. ADVISORS LP | 971.614 | 971.614 | 0,0% | 5.062.109 | 2,17 |
| ADAR1 Capital Management, LLC | 940.512 | 1.136.799 | -17,3% | 4.900.068 | 2,10 |
| BANK OF AMERICA CORP /DE/ | 925.918 | 495.904 | +86,7% | 4.824.033 | 2,07 |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 31.03.2026 | ✓ | 113 | 53,5 | 279 |
| 31.12.2025 | ✓ | 105 | 41,3 | 10.387 |
| 30.09.2025 | ✓ | 80 | 26,6 | 8.414 |
| 30.06.2025 | ✓ | 74 | 29,1 | 5.868 |
| 31.03.2025 | ✓ | 58 | 29,5 | 7.548 |
| 31.12.2024 | ✓ | 58 | 33,0 | 9.035 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) ⓘ |
|---|---|---|
| Sio Capital Management, LLC | 1.715.394 | 9.143.050 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.043.478 | 5.561.738 |
| Maven Securities LTD | 754.626 | 4.022.157 |
| SPHERA FUNDS MANAGEMENT LTD. | 650.000 | 3.464.500 |
| Burkehill Global Management, LP | 450.000 | 2.398.500 |
| Alyeska Investment Group, L.P. | 350.000 | 1.865.500 |
| AMERIPRISE FINANCIAL INC | 153.985 | 820.740 |
| Walleye Capital LLC | 145.876 | 777.519 |
| Monashee Investment Management LLC | 125.000 | 666.250 |
| XTX Topco Ltd | 115.363 | 614.885 |
Top 10 Aufstocker
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| ADAR1 Capital Management, LLC | 1.136.799 | 1.101.576 | +3127.4 % | 6.059.139 |
| JANUS HENDERSON GROUP PLC | 5.141.616 | 910.285 | +21.5 % | 27.379.105 |
| Integral Health Asset Management, LLC | 2.250.000 | 850.000 | +60.7 % | 11.992.500 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1.259.427 | 814.983 | +183.4 % | 6.712.746 |
| Velan Capital Investment Management LP | 2.834.652 | 695.652 | +32.5 % | 15.108.695 |
| 5AM Venture Management, LLC | 1.369.782 | 569.782 | +71.2 % | 7.300.938 |
| VANGUARD GROUP INC | 2.391.903 | 487.747 | +25.6 % | 12.748.844 |
| BAKER BROS. ADVISORS LP | 971.614 | 434.782 | +81.0 % | 5.178.703 |
| CITADEL ADVISORS LLC | 931.041 | 400.187 | +75.4 % | 4.962.449 |
| UBS Group AG | 1.215.537 | 372.463 | +44.2 % | 6.478.812 |
Top 10 Verkäufer
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| Nuveen, LLC | 86.501 | -196.980 | -69.5 % | 461.051 |
| Catalio Capital Management, LP | 1.446.254 | -54.539 | -3.6 % | 7.708.534 |
| GSA CAPITAL PARTNERS LLP | 52.332 | -49.156 | -48.4 % | 279 |
| RENAISSANCE TECHNOLOGIES LLC | 266.807 | -47.493 | -15.1 % | 1.422.081 |
| CIBC WORLD MARKET INC. | 228.895 | -46.099 | -16.8 % | 1.220.010 |
| BNP PARIBAS FINANCIAL MARKETS | 7.617 | -42.838 | -84.9 % | 40.599 |
| BAILARD, INC. | 24.417 | -12.252 | -33.4 % | 130.143 |
| Invesco Ltd. | 17.514 | -7.655 | -30.4 % | 93.350 |
| RHUMBLINE ADVISERS | 26.865 | -7.272 | -21.3 % | 143.185 |
| NEW YORK STATE COMMON RETIREMENT FUND | 15.000 | -4.700 | -23.9 % | 79.950 |
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Zweck |
|---|---|---|---|---|---|---|
| 15.05.2026 | JANUS HENDERSON GROUP PLC | Passiv (13G/A) | 9,60 % | 5.207.011 | -0,40 pp | |
| 27.04.2026 | BlackRock, Inc. | Passiv (13G) | 6,30 % | 3.387.459 | +1,60 pp | |
| 02.03.2026 | Millennium Group Management LLC | Passiv (13G) | 5,10 % | 2.759.231 | Neu | |
| 02.03.2026 | Millennium Management LLC | Passiv (13G) | 5,10 % | 2.759.231 | Neu | |
| 02.03.2026 | Israel A. Englander | Passiv (13G) | 5,10 % | 2.759.231 | Neu | |
| 17.02.2026 | JANUS HENDERSON GROUP PLC | Passiv (13G/A) | 10,00 % | 5.141.616 | -1,00 pp | |
| 21.01.2026 | BlackRock, Inc. | Passiv (13G/A) | 4,70 % | 2.408.868 | -0,90 pp | |
| 14.11.2025 | Janus Henderson Biotech Innovation Master Fund Ltd | Passiv (13G/A) | 9,30 % | 3.579.068 | +0,20 pp | |
| 14.11.2025 | JANUS HENDERSON GROUP PLC | Passiv (13G/A) | 11,00 % | 4.231.331 | +0,40 pp | |
| 14.08.2025 | Rajeev Shah | Passiv (13G/A) | 4,90 % | 1.971.765 | -5,00 pp | |
| 14.08.2025 | RA Capital Healthcare Fund, L.P. | Passiv (13G/A) | 4,90 % | 1.971.765 | -5,00 pp | |
| 14.08.2025 | RA Capital Management, L.P. | Passiv (13G/A) | 4,90 % | 1.971.765 | -5,00 pp | |
| 14.08.2025 | Peter Kolchinsky | Passiv (13G/A) | 4,90 % | 1.971.765 | -5,00 pp | |
| 14.08.2025 | JANUS HENDERSON GROUP PLC | Passiv (13G/A) | 10,60 % | 4.102.620 | +0,10 pp | |
| 14.08.2025 | Janus Henderson Biotech Innovation Master Fund Ltd | Passiv (13G/A) | 9,10 % | 3.512.932 | 0,00 pp | |
| 17.07.2025 | BlackRock, Inc. | Passiv (13G) | 5,60 % | 2.143.880 | Neu | |
| 14.05.2025 | Janus Henderson Biotech Innovation Master Fund Ltd | Passiv (13G/A) | 9,10 % | 3.356.076 | 0,00 pp | |
| 14.05.2025 | JANUS HENDERSON GROUP PLC | Passiv (13G/A) | 10,50 % | 3.862.551 | +0,20 pp | |
| 12.05.2025 | Robert Atchinson | Passiv (13G/A) | Ausstieg | 0 | -6,56 pp | |
| 12.05.2025 | Phillip Gross | Passiv (13G/A) | Ausstieg | 0 | -6,56 pp | |
| 12.05.2025 | Adage Capital Management, L.P. | Passiv (13G/A) | Ausstieg | 0 | -6,56 pp | |
| 28.04.2025 | Opaleye Management, Inc. | Passiv (13G/A) | 4,71 % | 1.730.000 | -0,61 pp | |
| 07.03.2025 | Janus Henderson Biotech Innovation Master Fund Ltd | Passiv (13G/A) | 9,10 % | 3.356.076 | +3,10 pp | |
| 07.03.2025 | JANUS HENDERSON GROUP PLC | Passiv (13G/A) | 10,30 % | 3.788.176 | +3,70 pp | |
| 14.02.2025 | Opaleye Management, Inc. | Passiv (13G/A) | 5,32 % | 1.825.000 | Neu | |
| 14.02.2025 | RA Capital Management, L.P. | Passiv (13G/A) | 9,90 % | 3.431.713 | -0,09 pp | |
| 14.02.2025 | Peter Kolchinsky | Passiv (13G/A) | 9,90 % | 3.431.713 | -0,09 pp | |
| 14.02.2025 | RA Capital Healthcare Fund, L.P. | Passiv (13G/A) | 9,90 % | 3.431.713 | -0,09 pp | |
| 14.02.2025 | Rajeev Shah | Passiv (13G/A) | 9,90 % | 3.431.713 | -0,09 pp | |
| 14.02.2025 | Janus Henderson Biotech Innovation Master Fund Ltd | Passiv (13G) | 6,00 % | 5.448.687 | Neu | |
| 14.02.2025 | JANUS HENDERSON GROUP PLC | Passiv (13G) | 6,60 % | 2.271.832 | Neu | |
| 14.02.2025 | Citadel GP LLC | Passiv (13G/A) | 4,60 % | 1.612.531 | -1,10 pp | |
| 14.02.2025 | Citadel Advisors LLC | Passiv (13G/A) | 4,60 % | 1.612.531 | -1,10 pp | |
| 14.02.2025 | Kenneth Griffin | Passiv (13G/A) | 4,70 % | 1.627.734 | -1,00 pp | |
| 14.02.2025 | Citadel Advisors Holdings LP | Passiv (13G/A) | 4,60 % | 1.612.531 | -1,10 pp | |
| 14.02.2025 | Citadel Securities LLC | Passiv (13G/A) | 0,00 % | 15.203 | 0,00 pp | |
| 14.02.2025 | Citadel Securities Group LP | Passiv (13G/A) | 0,00 % | 15.203 | 0,00 pp | |
| 14.02.2025 | Citadel Securities GP LLC | Passiv (13G/A) | 0,00 % | 15.203 | 0,00 pp | |
| 14.02.2025 | Woodline Partners LP | Passiv (13G/A) | 3,90 % | 1.331.258 | -3,50 pp | |
| 12.02.2025 | Phillip Gross | Passiv (13G) | 6,56 % | 2.250.000 | Neu |
Stammdaten
Protara Therapeutics, Inc., ein Biopharmaka-Unternehmen in der klinischen Entwicklungsphase, ist tätig in der Identifizierung und Weiterentwicklung transformativer Therapien zur Behandlung von Krebs und seltenen Erkrankungen. Das Hauptprogramm des Unternehmens ist TARA-002, eine experimentelle Zelltherapie zur Behandlung lymphatischer Malformationen. Das Unternehmen entwickelt auch intravenöses Cholinchlorid, eine experimentelle Phospholipid-Substrat-Ersatztherapie zur Behandlung von Lebererkrankungen, die mit Darmversagen verbunden sind. Das Unternehmen war zuvor unter dem Namen ArTara Therapeutics, Inc. bekannt und änderte seinen Namen im Mai 2020 zu Protara Therapeutics, Inc. Protara Therapeutics, Inc. hat seinen Sitz in New York, New York.
Unternehmen & Branche
| Name | Protara Therapeutics, Inc. |
|---|---|
| Ticker | TARA |
| CIK | 0001359931 |
| Boerse | Nasdaq |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2836 · Biological Products, (No Diagnostic Substances) |
Wertpapier & Kennzahlen
| CUSIP | 74365U107 |
|---|---|
| ISIN | US74365U1079 |
| Typ | Common Stock |
| Marktkapitalisierung | 196,9 Mio. USD |
| Beta | 1,49 |
Bewertung
| KBV (P/B) | 1,00 vs. 0,47 (2021) ▲ |
|---|---|
| FCF-Rendite | -28,7 % vs. -46,3 % (2021) ▲ |
Qualität & Bilanz
| ROIC | -28,8 % vs. -27,9 % (2021) ▼ |
|---|
Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2021. Kennzahlen erklärt →
Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
| Kennzahl | 2021 | 2022 | 2023 | 2024 | 2025 | Verlauf |
|---|---|---|---|---|---|---|
| Bewertung | ||||||
| KBV (P/B) | 0,47 | 0,30 | 0,31 | 1,11 | 1,45 | |
| FCF-Rendite | -46,3 % | -88,0 % | -176,0 % | -19,4 % | -19,8 % | |
| Buyback-Rendite | 0,3 % | 0,3 % | 0,4 % | – | – | |
| Qualität & Bilanz | ||||||
| ROIC | -27,9 % | -60,8 % | -54,8 % | -26,0 % | -28,8 % | |
Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).
Externe Quelle:
SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »
Finanzkennzahlen (SEC XBRL) ⓘ
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-31 | 10-Q | -17.782.000 | -0,31 | 191.923.000 | 181.208.000 | |
| 2025-12-31 | 10-K | -57.439.000 | -1,34 | 209.468.000 | 196.412.000 | |
| 2025-09-30 | 10-Q | -13.258.000 | -0,31 | 144.636.000 | 132.291.000 | |
| 2025-06-30 | 10-Q | -14.960.000 | -0,35 | 156.933.000 | 144.423.000 | |
| 2025-03-31 | 10-Q | -11.914.000 | -0,29 | 168.559.000 | 158.484.000 | |
| 2024-12-31 | 10-K | -44.596.000 | -2,17 | 181.454.000 | 167.134.000 | |
| 2024-09-30 | 10-Q | -11.219.000 | -0,50 | 94.090.000 | 81.791.000 | |
| 2024-06-30 | 10-Q | -9.513.000 | -0,45 | 101.647.000 | 92.050.000 | |
| 2024-03-31 | 10-Q | -11.095.000 | -0,97 | 68.134.000 | 58.406.000 | |
| 2023-12-31 | 10-K | -40.420.000 | -3,57 | 78.954.000 | 68.321.000 | |
| 2023-09-30 | 10-Q | -9.860.000 | -0,87 | 88.467.000 | 76.956.000 | |
| 2023-06-30 | 10-Q | -11.294.000 | -1,00 | 95.141.000 | 85.225.000 | |
| 2023-03-31 | 10-Q | -9.045.000 | -0,80 | 106.405.000 | 94.768.000 | |
| 2022-12-31 | 10-K | -65.952.000 | -5,86 | 113.290.000 | 102.083.000 | |
| 2022-09-30 | 10-Q | -7.691.000 | -0,68 | 148.591.000 | 139.178.000 | |
| 2022-06-30 | 10-Q | -8.539.000 | -0,76 | 154.884.000 | 145.458.000 | |
| 2022-03-31 | 10-Q | -10.755.000 | -0,96 | 161.256.000 | 152.235.000 | |
| 2021-12-31 | 10-K | -47.252.000 | -4,21 | 172.596.000 | 161.914.000 | |
| 2021-09-30 | 10-Q | -10.777.000 | -0,96 | 180.697.000 | 170.406.000 | |
| 2021-06-30 | 10-Q | -12.782.000 | -1,14 | 188.892.000 | 178.405.000 |
Quartalsergebnisse (Earnings) ⓘ
| Quartal | Stichtag | Verkündet | Umsatz | EPS |
|---|---|---|---|---|
| Q1 2026 | 31.03.2026 | 13.05.2026 | – | -0,31 |
| Q3 2025 | 30.09.2025 | 10.11.2025 | – | -0,31 |
| Q2 2025 | 30.06.2025 | 10.11.2025 | – | -0,35 |
| Q1 2025 | 31.03.2025 | 13.05.2026 | – | -0,29 |
| Q3 2024 | 30.09.2024 | 10.11.2025 | – | -0,50 |
| Q2 2024 | 30.06.2024 | 10.11.2025 | – | -0,45 |
| Q1 2024 | 31.03.2024 | 10.11.2025 | – | -0,97 |
| Q3 2023 | 30.09.2023 | 12.11.2024 | – | -0,87 |
| Q2 2023 | 30.06.2023 | 12.11.2024 | – | -1,00 |
Einreichungs-Historie (10-K / 10-Q)
SEC-Einreichungs-Historie der Quartalsberichte (10-Q) und Jahresberichte
(10-K) der letzten sechs Jahre. Die Spalte „Verzögerung" zeigt die
Tage zwischen Berichtsstichtag und tatsächlicher Einreichung.
Suffix /A kennzeichnet nachträgliche Berichtigungen.
| Eingereicht | Form | Berichtsperiode | Verzögerung | |
|---|---|---|---|---|
| 13.05.2026 | 10-Q | – | – | SEC » |
| 10.03.2026 | 10-K | 31.12.2025 | 69 Tage | SEC » |
| 10.11.2025 | 10-Q | 30.09.2025 | 41 Tage | SEC » |
| 11.08.2025 | 10-Q | 30.06.2025 | 42 Tage | SEC » |
| 08.05.2025 | 10-Q | 31.03.2025 | 38 Tage | SEC » |
| 05.03.2025 | 10-K | 31.12.2024 | 64 Tage | SEC » |
| 12.11.2024 | 10-Q | 30.09.2024 | 43 Tage | SEC » |
| 06.08.2024 | 10-Q | 30.06.2024 | 37 Tage | SEC » |
| 02.05.2024 | 10-Q | 31.03.2024 | 32 Tage | SEC » |
| 13.03.2024 | 10-K | 31.12.2023 | 73 Tage | SEC » |
| 03.11.2023 | 10-Q | 30.09.2023 | 34 Tage | SEC » |
| 03.08.2023 | 10-Q | 30.06.2023 | 34 Tage | SEC » |
| 04.05.2023 | 10-Q | 31.03.2023 | 34 Tage | SEC » |
| 08.03.2023 | 10-K | 31.12.2022 | 67 Tage | SEC » |
| 03.11.2022 | 10-Q | 30.09.2022 | 34 Tage | SEC » |
| 09.08.2022 | 10-Q | 30.06.2022 | 40 Tage | SEC » |
| 05.05.2022 | 10-Q | 31.03.2022 | 35 Tage | SEC » |
| 09.03.2022 | 10-K | 31.12.2021 | 68 Tage | SEC » |
| 04.11.2021 | 10-Q | 30.09.2021 | 35 Tage | SEC » |
| 05.08.2021 | 10-Q | 30.06.2021 | 36 Tage | SEC » |
| 06.05.2021 | 10-Q | 31.03.2021 | 36 Tage | SEC » |
| 11.03.2021 | 10-K | 31.12.2020 | 70 Tage | SEC » |
| 12.11.2020 | 10-Q | 30.09.2020 | 43 Tage | SEC » |
| 31.07.2020 | 10-Q | 30.06.2020 | 31 Tage | SEC » |
Kritische 8-K Meldungen ⓘ
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 18.03.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 30.01.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain… |
| 18.07.2022 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 21.06.2022 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 10.01.2022 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 18.10.2021 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 10.06.2021 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 19.04.2021 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02.Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 02.02.2021 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 07.12.2020 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 24.07.2020 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 11.02.2020 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02.Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 10.01.2020 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 of this Current Report on Form 8-K regarding the Company’s board of directors and executive officers… |
Fail-to-Deliver (6 Monate) ⓘ
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-04-27 | 261 | 5,13 | 1.339 |
| 2026-04-21 | 96 | 5,30 | 509 |
| 2026-04-16 | 51 | 5,21 | 266 |
| 2026-03-23 | 4.976 | 5,21 | 25.925 |
| 2026-03-18 | 816 | 5,45 | 4.447 |
| 2026-03-05 | 1.570 | 6,20 | 9.734 |
| 2026-03-04 | 2.060 | 6,15 | 12.669 |
| 2026-02-27 | 11.500 | 5,77 | 66.355 |
| 2026-02-26 | 1.697 | 5,96 | 10.114 |
| 2026-02-25 | 679 | 5,47 | 3.714 |
| 2026-02-17 | 731 | 6,51 | 4.759 |
| 2026-02-10 | 41.081 | 6,48 | 266.205 |
| 2026-02-09 | 5.604 | 6,65 | 37.267 |
| 2026-02-05 | 7.207 | 6,71 | 48.359 |
| 2026-02-04 | 6.894 | 6,75 | 46.535 |
| 2026-02-03 | 6.411 | 7,04 | 45.133 |
| 2026-02-02 | 16.160 | 7,08 | 114.413 |
| 2026-01-30 | 13.784 | 7,00 | 96.488 |
| 2026-01-29 | 27.257 | 7,17 | 195.433 |
| 2026-01-26 | 1.589 | 6,19 | 9.836 |
| 2026-01-22 | 5.207 | 5,77 | 30.044 |
| 2026-01-12 | 81 | 5,75 | 466 |
| 2026-01-05 | 3.187 | 5,38 | 17.146 |
| 2025-12-22 | 71 | 5,27 | 374 |
| 2025-12-16 | 3.439 | 5,50 | 18.915 |
| 2025-12-15 | 7.919 | 5,70 | 45.138 |